Company Directory / research
PrivateFor profitresearchGraefelfing, Germany
Isarna Therapeutics
Isarna Therapeutics is a biotechnology company.
- Founded
- 1998 28 years ago
- Staff
- 1-10 band, as listed
- Followers
- - on LinkedIn
- Funding
- $124M as listed, currency not stated
Set against six million companies
Size
1-10 people: larger than 0% of companies with a size listed
Age
28 years old.
Reach
Website ranked #13,006,558 in the world for traffic, about 78 visits a month.
What it does
BiotechnologyMedicalTherapeutics
Funding, as listed
$124M currency not stated
- Rounds7
- LatestSeries unknown, Apr 2014
- Investors6, 2 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Isarna Therapeutics, field by field. Contact details are held but never shown.
The company
- Name
- Isarna Therapeutics
- Type
- For profit
- Status
- Private
- Founded
- 1998
- Founders
- Karl-Hermann Schlingensiepen
- Industry
- research
- Categories
- Biotechnology, Medical, Therapeutics
Where
- City
- Graefelfing
- Country
- Germany
- Markets
- European Union (EU), Europe, Middle East, and Africa (EMEA)
Size and reach
- Staff band
- 1-10
- Web traffic rank
- #13,006,558
- Monthly web visits
- 78
Funding, as listed
- Total
- 124,222,924 (currency not stated)
- Rounds
- 7
- Latest round
- Series unknown
- Latest round date
- Apr 2014
- Investors
- 6
- Lead investors
- 2
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Isarna Therapeutics may be growing as evidenced by their recent advancements and activities in the field of ophthalmology. The company has been making significant strides in revolutionizing ophthalmology with antisense oligonucleotides, which indicates a focus on innovation and development of new treatments. Additionally, Isarna Therapeutics has announced Phase 2 clinical data presentations at upcoming ophthalmology conferences, suggesting progress in their clinical trials and an active role in the scientific community. These developments are indicative of a company that is advancing in its clinical programs and potentially expanding its presence in the biotechnology and therapeutics industry.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
research in Germany.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 106,645 companies in Germany and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.